Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
The purpose of this study is to determine the safety and effectiveness of the study drug, GSK249320, an experimental new drug not yet approved for treatment of patients who have had a stroke. Phone: 904-244-9514 Email: Nader.firstname.lastname@example.org
Keywordssafety, drug, stroke, comparison
Principal InvestigatorNADER ANTONIOS, CLINICAL ASSISTANT PROFESSOR
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.